BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30650180)

  • 1. Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease.
    Pan J; Kavanagh K; Cuschieri K; Pollock KG; Gilbert DC; Millan D; Bell S; Graham SV; Williams ARW; Cruickshank ME; Palmer T; Wakeham K
    Int J Cancer; 2019 Jul; 145(2):427-434. PubMed ID: 30650180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
    Ebisch RMF; Rutten DWE; IntHout J; Melchers WJG; Massuger LFAG; Bulten J; Bekkers RLM; Siebers AG
    J Clin Oncol; 2017 Aug; 35(22):2542-2550. PubMed ID: 28541790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updating the natural history of human papillomavirus and anogenital cancers.
    Moscicki AB; Schiffman M; Burchell A; Albero G; Giuliano AR; Goodman MT; Kjaer SK; Palefsky J
    Vaccine; 2012 Nov; 30 Suppl 5(0 5):F24-33. PubMed ID: 23199964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
    Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative risk of noncervical high-risk human papillomavirus-related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population-based study.
    Loopik DL; Ebisch RM; IntHout J; Melchers WJ; Massuger LF; Bekkers RL; Siebers AG
    Int J Cancer; 2020 Aug; 147(3):897-900. PubMed ID: 31846057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anal and Cervical High-Risk Human Papillomavirus Genotyping in Women With and Without Genital Neoplasia.
    Bregar AJ; Cronin B; Luis C; DiSilvestro P; Schechter S; Pisharodi L; Raker C; Clark M; Robison K
    J Low Genit Tract Dis; 2018 Apr; 22(2):115-119. PubMed ID: 29481422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
    J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV in genital cancers (at the exception of cervical cancer) and anal cancers.
    de Sanjosé S; Bruni L; Alemany L
    Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of ano-genital and head and neck malignancies in women with a previous diagnosis of cervical intraepithelial neoplasia.
    Gaudet M; Hamm J; Aquino-Parsons C
    Gynecol Oncol; 2014 Sep; 134(3):523-6. PubMed ID: 25042671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of human papillomavirus infection and related diseases in Israel.
    Shavit O; Roura E; Barchana M; Diaz M; Bornstein J
    Vaccine; 2013 Nov; 31 Suppl 8():I32-41. PubMed ID: 24229717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study.
    Fokom Domgue J; Messick C; Milbourne A; Guo M; Salcedo MP; Dahlstrom KR; Chiao EY; Deshmukh AA; Sturgis EM; Schmeler KM
    Gynecol Oncol; 2019 May; 153(2):266-270. PubMed ID: 30827725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
    J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
    Strander B; Hällgren J; Sparén P
    BMJ; 2014 Jan; 348():f7361. PubMed ID: 24423603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
    Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
    Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities.
    Louchini R; Goggin P; Steben M
    Chronic Dis Can; 2008; 28(3):99-106. PubMed ID: 18341764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.